Abstract
The aim of this review is to collect, systematize and contrast the many recent advances in xanthones biochemistry and biology. Advances in understanding xanthones antimicrobial activities will be discussed. Pharmacological and biological properties of naturally occurring as well as synthetic xanthones will be considered in an evaluation of their medical values.
Keywords: Xanthones, antimicrobial, antimalarial, pharmacological and biological properties
Anti-Infective Agents in Medicinal Chemistry
Title: Pharmacological and Biological Activities of Xanthones
Volume: 5 Issue: 1
Author(s): Jean Fotie and D. S. Bohle
Affiliation:
Keywords: Xanthones, antimicrobial, antimalarial, pharmacological and biological properties
Abstract: The aim of this review is to collect, systematize and contrast the many recent advances in xanthones biochemistry and biology. Advances in understanding xanthones antimicrobial activities will be discussed. Pharmacological and biological properties of naturally occurring as well as synthetic xanthones will be considered in an evaluation of their medical values.
Export Options
About this article
Cite this article as:
Fotie Jean and Bohle S. D., Pharmacological and Biological Activities of Xanthones, Anti-Infective Agents in Medicinal Chemistry 2006; 5 (1) . https://dx.doi.org/10.2174/187152106774755563
DOI https://dx.doi.org/10.2174/187152106774755563 |
Print ISSN 1871-5214 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6018 |
Related Articles
-
Editorial [Hot Topic: Cardiovascular Diagnostic Testing: Use and Limits of Biochemical Markers (Executive Editors: Aurelio Leone and Stefano Taddei)]
Current Pharmaceutical Design Design of Multifunctional Compounds for Cardiovascular Disease: From Natural Scaffolds to “Classical” Multitarget Approach
Current Medicinal Chemistry Introduction: Advancing Drug Discovery for Alzheimers Disease [ ISOA Fifth Annual Investigators Meeting “Recent Advances in Drug Discovery and Development for Alzheimers Disease” Sponsored by Elan Pharmaceuticals Inc, The Graphic Expression, Glaxo Smith Kline Pharmaceuticals, Neurochem Inc, Pfizer Inc. (Guest Editors: Howard M. Fillit and Lorenzo M. Refolo)]
Current Alzheimer Research Novel Targets for Cardiac Antiarrhythmic Drug Development
Current Pharmaceutical Design Influence of Lifestyle Measures on Hypertriglyceridaemia
Current Drug Targets Xanthine Oxidase and its Role as Target in Cardiovascular Disease: Cardiovascular Protection by Enzyme Inhibition?
Current Pharmaceutical Design Cardiac Remodeling and Exercise Training in Hypertension
Current Hypertension Reviews Heart Failure
Current Hypertension Reviews The Missed Tc-99m Radiopharmaceuticals for Cardiac Imaging
Current Radiopharmaceuticals HIV: A Raft-Targeting Approach for Prevention and Therapy Using Plant-Derived Compounds (Review)
Current Drug Targets Dietary Potassium in Cardiovascular Prevention: Nutritional and Clinical Implications
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Drug-Delivery Systems of Green Tea Catechins for Improved Stability and Bioavailability
Current Medicinal Chemistry ATP-Sensitive K+ Channels: Current and Putative Target for the Prevention and Treatment of Cardiovascular Diseases
Vascular Disease Prevention (Discontinued) Cardiovascular Effects of Current and Future Anti-Obesity Drugs
Current Vascular Pharmacology Patient-Specific Induced Pluripotent Stem Cell Models in Mitochondrial Diseases
Current Stem Cell Research & Therapy Medical Image Processing Technology for Diagnosing and Treating Cancers
Recent Patents on Biomedical Engineering (Discontinued) Cerebral Amyloid Angiopathy-related Intracerebral Hemorrhage Score For Predicting Outcome
Current Neurovascular Research High-Density Lipoprotein-Mediated Anti-Atherosclerotic and Endothelial-Protective Effects: A Potential Novel Therapeutic Target in Cardiovascular Disease
Current Pharmaceutical Design The Role of Natural Killer T Cells in Atherosclerosis
Current Immunology Reviews (Discontinued) Severe Psychiatric Disorders in Mid-Life and Risk of Dementia in Late- Life (Age 65-84 Years): A Population Based Case-Control Study
Current Alzheimer Research